Syndesi Therapeutics is a pharmaceutical company focused on developing a drug candidate for the treatment of cognitive disorders associated with neurological conditions. Their main goal is to develop molecules that modulate the synaptic vesicle protein SV2A, which is crucial for synaptic transmission in the brain. By regulating synaptic transmission, Syndesi aims to provide a promising approach to...